SKI Market

Indian Indices

Nifty

26,013.45 103.40
(0.40%)

Sensex

84,950.95 388.17
( 0.46%)

Bank Nifty

58,962.70 445.15
( 0.76%)

Nifty IT

36,375.20 73.95
( 0.20%)

Global Indices

Nasdaq

47,163.83 -314.39
(-0.66%)

Dow Jones

6,754.35 -4.14
(-0.06%)

Hang Seng

50,246.57 -129.96
(-0.26%)

Nikkei 225

9,693.83 -113.85
(-1.16%)

Forex

USD-INR

88.71 0.12
(0.13%)

EUR-INR

103.04 0.44
(0.43%)

GBP-INR

116.72 0.41
(0.35%)

JPY-INR

0.57 0.00
(0.16%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Astal Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

512600

INE307N01014

33.4345311

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

10.86

101.31

EPS(TTM)

Face Value()

Div & Yield %

8.66

Back

Silgo Retail standalone net profit rises 19.35% in the June 2025 quarter

Aug 14,2025

Net profit of Silgo Retail rose 19.35% to Rs 1.11 crore in the quarter ended June 2025 as against Rs 0.93 crore during the previous quarter ended June 2024. Sales declined 2.75% to Rs 10.97 crore in the quarter ended June 2025 as against Rs 11.28 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	10.97	11.28	-3
OPM %	13.58	11.26	-
PBDT	1.49	1.26	18
PBT	1.48	1.24	19
NP	1.11	0.93	19

26,013.45 103.40 (0.40%)

84,950.95 388.17 ( 0.46%)

58,962.70 445.15 ( 0.76%)

36,375.20 73.95 ( 0.20%)

47,163.83 -314.39 (-0.66%)

6,754.35 -4.14 (-0.06%)

50,246.57 -129.96 (-0.26%)

9,693.83 -113.85 (-1.16%)

88.71 0.12 (0.13%)

103.04 0.44 (0.43%)

116.72 0.41 (0.35%)

0.57 0.00 (0.16%)